Peptides Academy

Peptides Academy answers questions about peptides from the research dossiers behind its courses. Every checkable sentence in a dossier quotes its source verbatim, so answers come with numbered citations to PubMed papers, clinical trial registrations and regulator documents.

What it covers: 28 peptides, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), retatrutide, BPC-157, TB-500, GHK-Cu, ipamorelin, CJC-1295, PT-141, Selank, Semax, epithalon, MOTS-c and thymosin alpha-1, plus a general foundations guide.

What you can ask:

• What a peptide is and where it came from
• What the human and animal studies found, kept separate by species, route and study type
• Regulatory and anti-doping status (FDA, compounding rules, WADA)
• What is still unknown
• How two or three peptides compare
• Which studies looked at a topic (for example BPC-157 and tendon healing), with each paper's DOI or PubMed link and what the dossier says about it

Each answer links to the matching Peptides Academy course for people who want to go deeper.

Who it is for: anyone who wants the evidence on a peptide without the hype, from complete beginners to clinicians and researchers.

Limitations: this is education, not medical advice. It does not give dosing, sourcing or self-administration guidance, and it covers only the peptides listed above. The research reflects each dossier's source snapshot date.